胎儿生长受限（fetal growth restriction，FGR）是围产儿患病和死亡的主要原因之一，且可能导致远期不良结局。中华医学会围产医学分会胎儿医学学组、中华医学会妇产科学分会产科学组，以及国家重点研发计划《建立我国胎儿生长曲线和胎儿生长受限干预体系的全链条研究》部分项目骨干基于2019年我国FGR专家共识，结合2019年后多项国际FGR诊治指南，围绕FGR的定义、诊断、临床处理及产后评估，制定了“胎儿生长受限临床诊治标准化表单管理专家共识”，以进一步规范疾病的诊治，推动多中心临床研究的开展，为FGR临床诊治提供有力的循证依据，并为后续相关指南奠定基础。
Fetal growth restriction (FGR) is one of the primary causes of morbidity and mortality during the perinatal period and may lead to adverse long-term outcomes. Based on the 2019 expert consensus on FGR in China, and in conjunction with multiple international FGR diagnosis and treatment guidelines published after 2019, Fetal Medicine Subgroup, Society of Perinatal Medicine, Chinese Medical Association, and Obstetrics Subgroup, Society of Obstetrics and Gynecology, Chinese Medical Association, along with core members from the National Key Research and Development Program entitled "Integrated Research on Establishing Fetal Growth Curves and an Intervention System for FGR in China," have formulated an expert consensus on standardized checklists for the clinical diagnosis and treatment of FGR. This consensus focuses on the definition, diagnosis, clinical management, and postnatal assessment of FGR, aiming to further standardize the management promote multicenter clinical research, provide robust evidence-based support for FGR clinical management, and lay the groundwork for subsequent guideline development.
Sun Luming works at Department of Obstetrics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
中华医学会围产医学分会胎儿医学学组,中华医学会妇产科学分会产科学组,国家重点研发计划《建立我国胎儿生长曲线和胎儿生长受限干预体系的全链条研究》部分项目骨干. 胎儿生长受限临床诊治标准化表单管理专家共识[J]. 中华围产医学杂志,2025,28(02)：89-97.
DOI:10.3760/cma.j.cn113903-20241112-00754版权归中华医学会所有。
未经授权，不得转载、摘编本刊文章，不得使用本刊的版式设计。
除非特别声明，本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
现在上海交通大学医学院附属新华医院产科
文档即答
智问智答
机器翻译
你好，我可以帮助您更好的了解本文，请向我提问您关注的问题。
